SEVERANCE AND CONSULTING AGREEMENT AND GENERAL RELEASESeverance and Consulting Agreement • October 4th, 2022 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
This Severance and Consulting Agreement and General Release (this “Agreement” or this “Agreement and General Release”), dated September 30, 2022, is entered into by Thomas Freeburg (“Executive”) and Interpace Biosciences, Inc. (the “Company”). Executive and the Company are jointly referred to in this Agreement as the “Parties” and both individually referred to in this Agreement as a “Party.”
